David N. Wald

机构：University Hospitals of Cleveland, Louis Stokes Cleveland VA Medical Center, Case Western Reserve University

发表论文 206 篇 · 总被引 3897 次 · h-index 31

代表论文

• Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial (2025 · EClinicalMedicine · 被引 9)
• Phase I Study Results of UF-Kure19, a CAR-T Product Manufactured in Less Than 1 Day, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma (2024 · Blood · 被引 8)
• A novel feeder cell based on 4-1BBL and membrane-bound IL-21/IL-15 induce highly expansion and anti-tumor effect of natural killer cells (2025 · BMC Biotechnology · 被引 5)
• Arsenic trioxide versus Realgar-Indigo naturalis formula in non-high-risk acute promyelocytic leukemia: a multicenter, randomized trial (2024 · Haematologica · 被引 3)
• In vivo tracking of CAR-T cells in tumors via nanobubble-based contrast enhanced ultrasound (2026 · Nanoscale Horizons · 被引 2)
• In vivo tracking of CAR-T cells in tumors via nanobubble-based contrast enhanced ultrasound (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)